NDC 0069-0249
Ruxience 500 mg per 50 mL injection, solution
On the label: Pfizer Laboratories Div Pfizer Inc.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Pfizer Ireland Pharmaceuticals Unlimited Company | Dublin, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyDec 15, 2023 · 5 inspections |
| Pfizer Manufacturing Belgium NV | Puurs-Sint-Amands, Belgium | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyJun 22, 2022 · 5 inspections |
| Samsung Biologics Co., Ltd. | Incheon, South Korea | Makes the active ingredient and tests it | Problems found, fixed voluntarilySep 1, 2023 · 3 inspections |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Andover, MA, United States | Makes the active ingredient | Problems found, fixed voluntarilyApr 8, 2026 · 5 inspections |
Product details
- Generic drug
- Rituximab: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 500 mg per 50 mL
- Approval
- BLA BLA761103
- On the market since
- Jan 23, 2020
- Package NDCs
0069-0249-01- Official label
- DailyMed (National Library of Medicine), updated Oct 2, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?